Clinical Value of Single-Projection Angiography-Derived FFR in Noninfarct-Related Artery
- Authors
- Kwon, Woochan; Choi, Ki Hong; Lee, Seung Hun; Hong, David; Shin, Doosup; Kim, Hyun Kuk; Park, Keun Ho; Choo, Eun Ho; Kim, Chan Joon; Kim, Min Chul; Hong, Young Joon; Ahn, Sung Gyun; Doh, Joon-Hyung; Lee, Sang Yeub; Park, Sang Don; Lee, Hyun-Jong; Kang, Min Gyu; Koh, Jin-Sin; Cho, Yun-Kyeong; Nam, Chang-Wook; Joh, Hyun Sung; Park, Taek Kyu; Yang, Jeong Hoon; Song, Young Bin; Choi, Seung-Hyuk; Jeong, Myung Ho; Gwon, Hyeon-Cheol; Hahn, Joo-Yong; Lee, Joo Myung
- Issue Date
- May-2024
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Keywords
- coronary angiography; fractional flow reserve, myocardial; myocardial infarction; percutaneous coronary intervention
- Citation
- CIRCULATION-CARDIOVASCULAR INTERVENTIONS, v.17, no.5
- Journal Title
- CIRCULATION-CARDIOVASCULAR INTERVENTIONS
- Volume
- 17
- Number
- 5
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74010
- DOI
- 10.1161/CIRCINTERVENTIONS.123.013844
- ISSN
- 1941-7640
1941-7632
- Abstract
- BACKGROUND: The Murray law-based quantitative flow ratio (mu FR) is an emerging technique that requires only 1 projection of coronary angiography with similar accuracy to quantitative flow ratio (QFR). However, it has not been validated for the evaluation of noninfarct-related artery (non-IRA) in acute myocardial infarction (AMI) settings. Therefore, our study aimed to evaluate the diagnostic accuracy of mu FR and the safety of deferring non-IRA lesions with mu FR >0.80 in the setting of AMI. METHODS: mu FR and QFR were analyzed for non-IRA lesions of patients with AMI enrolled in the FRAME-AMI trial (Fractional Flow Reserve Versus Angiography-Guided Strategy for Management of Non-Infarction Related Artery Stenosis in Patients With Acute Myocardial Infarction), consisting of fractional flow reserve (FFR)-guided percutaneous coronary intervention and angiography-guided percutaneous coronary intervention groups. The diagnostic accuracy of mu FR was compared with QFR and FFR. Patients were classified by the non-IRA mu FR value of 0.80 as a cutoff value. The primary outcome was a vessel-oriented composite outcome, a composite of cardiac death, non-IRA-related myocardial infarction, and non-IRA-related repeat revascularization. RESULTS: mu FR and QFR analyses were feasible in 443 patients (552 lesions). mu FR showed acceptable correlation with FFR (R=0.777; P<0.001), comparable C-index with QFR to predict FFR <= 0.80 (mu FR versus QFR: 0.926 versus 0.961, P=0.070), and shorter total analysis time (mean, 32.7 versus 186.9 s; P<0.001). Non-IRA with mu FR >0.80 and deferred percutaneous coronary intervention had a significantly lower risk of vessel-oriented composite outcome than non-IRA with performed percutaneous coronary intervention (3.4% versus 10.5%; hazard ratio, 0.37 [95% CI, 0.14-0.99]; P=0.048). CONCLUSIONS: In patients with multivessel AMI, mu FR of non-IRA showed acceptable diagnostic accuracy comparable to that of QFR to predict FFR <= 0.80. Deferred non-IRA with mu FR >0.80 showed a lower risk of vessel-oriented composite outcome than revascularized non-IRA. REGISTRATION:URL: https://www.clinicaltrials.gov; Unique identifier: NCT02715518.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74010)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.